MedTrace Logo

Screening Questionnaire for Respiratory Muscle Weakness and Sleep-disordered Breathing in Neuromuscular Disorders

NCT02833168 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 90

Last updated 2016-07-14

No results posted yet for this study

Summary

It is the aim of this project to develop and validate a German language screening questionnaire for symptoms of respiratory muscle weakness and sleep-disordered breathing (SDB) in patients with neuromuscular disorders.

Conditions

  • Neuromuscular Disorders

Interventions

OTHER

patient-filled questionnaires

All patients answer selected questionnaires on sleep-related symptoms, sleep quality, daytime performance, and health-related quality of life.

DEVICE

spiromanometry

Measurement of forced vital capacity, maximum inspiratory pressure and maximum expiratory pressure

Sponsors & Collaborators

  • Universität Münster

    lead OTHER

Principal Investigators

  • Matthias Boentert, MD · University Hospital Münster, Department of Sleep Medicine and Neuromuscular Disorders

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-04-30
Primary Completion
2016-12-31
Completion
2016-12-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02833168 on ClinicalTrials.gov